Advertisement
U.S. Markets closed

Labiana Health, S.A. (LAB.MC)

MCE - MCE Delayed Price. Currency in EUR
2.54000.0000 (0.00%)
At close: 12:40PM CEST

Labiana Health, S.A.

Avenida de Europa
34 letter D first floor
Pozuelo de Alarcón 28023
Spain
34 919 91 26 28
https://www.labiana.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 433

Key Executives

NameTitlePayExercisedYear Born
Mr. Manuel Ramos OrtegaPresident, CEO & DirectorN/AN/AN/A
Mr. Ignacio Yanez MinondoExecutive DirectorN/AN/AN/A
Ms. Sandra Villagrasa ClementeExecutive DirectorN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized, and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments and manufacturing services. Labiana Health S.A. was founded in 1958 and is based in Pozuelo de Alarcón, Spain.

Corporate Governance

Labiana Health, S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.